Ioka Akiko, Tsukuma Hideaki, Ajiki Wakiko, Oshima Akira
Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka 537-8511, Japan.
Jpn J Clin Oncol. 2005 Aug;35(8):464-9. doi: 10.1093/jjco/hyi125. Epub 2005 Jul 8.
Relative 5-year survival for cervical cancer has been reported to be lower in older women in Japan. A population-based study was carried out to clarify why increased age is associated with decreased survival in spite of a nationwide cervical cancer screening program having been carried out since 1982 in Japan.
The Osaka Cancer Registry's data were used to investigate associations between age groups and survival for cervical cancer patients. Survival analysis was restricted to the reported 8966 cases diagnosed in 1975-1996 who lived in Osaka Prefecture (except for Osaka City), or resided in Osaka City in 1993-1996, since active follow-up data on vital status 5 years after the diagnosis were available.
Relative 5-year survival for cervical cancer cases was lower in older age groups (88.6% in <30 years, 78.1% in 30-54 years, 67.7% in 55-64 years and 54.4% in 65+ years), as was the proportion of the detection by screening (6.3, 9.8, 9.2 and 6.0%), the proportion of the localized stage (83.0, 67.3, 51.0 and 42.7%) and the proportion of women who underwent surgery (79.2, 83.2, 65.6 and 35.2%). Among localized cases detected with screening, the survival in those > or =55 years old was >92% and almost comparable with that in 30 to 54 year olds, but significantly lower among those detected without screening.
Lower survival among older women was caused mainly by the presence of more advanced disease at diagnosis. Further extension of the nationwide cervical cancer screening program should result in improved diagnosis of earlier stage disease, which might improve differences of cervical cancer survival among these age groups.
据报道,日本老年女性宫颈癌的相对5年生存率较低。自1982年日本开展全国性宫颈癌筛查项目以来,进行了一项基于人群的研究,以阐明为何年龄增长与生存率下降相关。
利用大阪癌症登记处的数据调查宫颈癌患者年龄组与生存率之间的关联。生存分析仅限于1975 - 1996年诊断出的8966例病例,这些病例居住在大阪府(大阪市除外)或在1993 - 1996年居住在大阪市,因为有诊断后5年生命状态的有效随访数据。
老年年龄组宫颈癌病例的相对5年生存率较低(<30岁组为88.6%,30 - 54岁组为78.1%,55 - 64岁组为67.7%,65岁及以上组为54.4%),筛查检出比例(分别为6.3%、9.8%、9.2%和6.0%)、局部阶段比例(分别为83.0%、67.3%、51.0%和42.7%)以及接受手术的女性比例(分别为79.2%、83.2%、65.6%和35.2%)也较低。在筛查检出的局部病例中,≥55岁者的生存率>92%,与30至54岁者几乎相当,但未筛查检出者的生存率显著较低。
老年女性生存率较低主要是由于诊断时疾病分期较晚。进一步扩大全国性宫颈癌筛查项目应能改善早期疾病的诊断,这可能缩小这些年龄组宫颈癌生存率的差异。